109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
非编码 RNA 对癌症中髓源性抑制细胞的调控作用
Authors Luo K , Xu Y, Chen J, Song JJ, Zhang R, Zhang W, Jiang P
Received 1 July 2025
Accepted for publication 16 October 2025
Published 30 October 2025 Volume 2025:17 Pages 2567—2587
DOI https://doi.org/10.2147/CMAR.S550896
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Professor Seema Singh
Kengjun Luo,1 Ying Xu,2,3 Jiahao Chen,1 Jingyang JY Song,1 Rui Zhang,1 Wenbo Zhang,1 Pengcheng Jiang1
1Department of General Surgery, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, People’s Republic of China; 2Department of Laboratory Center, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, People’s Republic of China; 3Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu university, Zhenjiang, Jiangsu, 212013, People’s Republic of China
Correspondence: Wenbo Zhang, Department of General Surgery, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212000, People’s Republic of China, Email wb.zhan@hotmail.com Pengcheng Jiang, Department of General Surgery, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212000, People’s Republic of China, Email pc_jsu@126.com
Abstract: Myeloid-derived suppressor cells (MDSCs) arise from myeloid progenitors in the bone marrow and, under the influence of tumor- and immune-cell-derived cytokines, chemokines, and growth factors, enhance immunosuppressive activity within the tumor microenvironment (TME). Noncoding RNAs (ncRNAs)—including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs)—have emerged as critical regulators of MDSCs biology. Recent evidence has shown that ncRNAs are intimately involved in MDSCs recruitment, differentiation, and suppressive function by modulating key signaling pathways, including STAT3, NF-κB, and PI3K/AKT. Mechanistically, ncRNAs act through epigenetic control (eg, histone modifications and chromatin remodeling), post-transcriptional regulation (eg, miRNA sponging), and fine-tuning of gene networks. These insights highlight RNA-based strategies that target ncRNAs to disrupt MDSCs-mediated immune suppression and potentiate antitumor immunity, while acknowledging ongoing challenges such as delivery specificity, stability, and off-target effects. This review synthesizes current understanding of how ncRNAs regulate MDSCs via major signaling axes and discusses implications for cancer progression and therapeutic development.
Keywords: ncRNAs, MDSCs, tumor, tumor microenvironment, tumor immunity
1Department of General Surgery, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, People’s Republic of China; 2Department of Laboratory Center, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, People’s Republic of China; 3Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu university, Zhenjiang, Jiangsu, 212013, People’s Republic of China
Correspondence: Wenbo Zhang, Department of General Surgery, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212000, People’s Republic of China, Email wb.zhan@hotmail.com Pengcheng Jiang, Department of General Surgery, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212000, People’s Republic of China, Email pc_jsu@126.com
Abstract: Myeloid-derived suppressor cells (MDSCs) arise from myeloid progenitors in the bone marrow and, under the influence of tumor- and immune-cell-derived cytokines, chemokines, and growth factors, enhance immunosuppressive activity within the tumor microenvironment (TME). Noncoding RNAs (ncRNAs)—including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs)—have emerged as critical regulators of MDSCs biology. Recent evidence has shown that ncRNAs are intimately involved in MDSCs recruitment, differentiation, and suppressive function by modulating key signaling pathways, including STAT3, NF-κB, and PI3K/AKT. Mechanistically, ncRNAs act through epigenetic control (eg, histone modifications and chromatin remodeling), post-transcriptional regulation (eg, miRNA sponging), and fine-tuning of gene networks. These insights highlight RNA-based strategies that target ncRNAs to disrupt MDSCs-mediated immune suppression and potentiate antitumor immunity, while acknowledging ongoing challenges such as delivery specificity, stability, and off-target effects. This review synthesizes current understanding of how ncRNAs regulate MDSCs via major signaling axes and discusses implications for cancer progression and therapeutic development.
Keywords: ncRNAs, MDSCs, tumor, tumor microenvironment, tumor immunity